Applying Guideline-Directed Care For Patients With T2D: Focus on Glucagon-Like Peptide-1 Receptor Agonists

Self enrollment
OBJECTIVES:

  • Explain how glucagon-like peptide-1 receptor agonists (GLP-1 RAs) function in treating type 2 diabetes (T2D) and their extra-glycemic effects
  • Examine safety considerations related to GLP-1 RAs and explore effective approaches for addressing adverse events associated with their use
  • Evaluate the guidance for comprehensive approaches to care and early management of T2D


Cost: FREE

Start Date: November 6, 2024
End Date: November 5, 2027

This course has been approved for 1.5 AOA Category 1-A CME Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This educational activity is supported by an independent educational grant from Novo Nordisk, Inc.

Category 1A
Enroll in Course